Clinical Trial

Genetic Frontotemporal Dementia Initiative for Neurodevelopment

Study acronym: GENFI-NeuroDev
Recruiting
View on ClinicalTrials.gov →
Summary
This is an international multi-centre cohort study of first and second degree family members of individuals who carry Frontotemporal Dementia (FTD) mutations in MAPT, GRN or C9ORF72 repeat expansions for youths between the ages 9-17.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-08; most recent amendment 2025-03-31.
Trial Details
NCT Number NCT05779813
Lead Sponsor Western University
Conditions Frontotemporal Dementia, Family Members
Enrollment 200 participants
Start Date 2023-03-31
Primary Completion 2033-03 (estimated)
Study Completion 2035-03 (estimated)
Updated on ClinicalTrials.gov 2025-04-03